|
 |
| 1-4
September, 2006 Pragati Maidan, New Delhi, India |
 |
|
|
Orchid`s new facility on stream bow
Orchid Chemicals and Pharmaceuticals expects its betalactam antibiotics facility.
The projected sale of the products, translating into Rs. 2700m, is expected to further strengthen the position of Orchid Chemicals as a leading company in the field.
In an informal interaction with presspersons, on the sidelines of the inauguration, K. Raghavendra Rao, Managing Director, said the company utilised the $75 million raised through a global depository receipt (GDR) issue to repay an old debt of $ 65 million. The move works out to an annualised savings of $4.5 million for the company.
On the anti-diabetes drug being developed by the company, he said it was being put through `90-day human trials.` During the initial testing, the drug produced some surprise positives — it also helped lower blood pressure and triglycerides. The company, which expects the drug to be in the market by March next, was in discussion with `some prospective partners` for marketing it.
Date: 14-Dec-2005
Back
|
|
 |
|
|
|
 |
